We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
The Bancorp
TBBK
$2.81B
| $290K | 0.05% |
8,870
-2,087
| -19% | -$64.2K |
|
|
REVG
752
DELISTED
REV Group
REVG
| $290K | 0.05% |
+21,840
| New | +$249K |
|
753
UGI
UGI
$7.91B
| $289K | 0.05% |
+10,725
| New | +$326K |
|
754
Helmerich & Payne
HP
$3.36B
| $288K | 0.05% |
8,113
-6,063
| -43% | -$207K |
|
755
Jazz Pharmaceuticals
JAZZ
$16B
| $287K | 0.05% |
2,318
+811
| +54% | +$109K |
|
756
Baker Hughes
BKR
$60.1B
| $287K | 0.05% |
+9,088
| New | +$265K |
|
757
Avis
CAR
$5.78B
| $286K | 0.05% |
+1,252
| New | +$229K |
|
758
Murphy Oil
MUR
$5.38B
| $285K | 0.05% |
+7,441
| New | +$275K |
|
759
DMC Global
BOOM
$117M
| $284K | 0.05% |
+15,997
| New | +$289K |
|
760
MSCI
MSCI
$41.5B
| $283K | 0.05% |
604
-3,160
| -84% | -$1.54M |
|
761
10x Genomics
TXG
$5.83B
| $283K | 0.05% |
+5,061
| New | +$274K |
|
762
Ingles Markets
IMKTA
$1.67B
| $282K | 0.05% |
+3,415
| New | +$294K |
|
763
SouthState Bank Corp
SSB
$10.2B
| $281K | 0.05% |
4,277
+1,254
| +41% | +$83.7K |
|
764
Encore Capital Group
ECPG
$2.03B
| $281K | 0.05% |
+5,788
| New | +$282K |
|
|
INFA
765
DELISTED
Informatica
INFA
| $281K | 0.05% |
15,190
-34,772
| -70% | -$574K |
|
766
Meritage Homes
MTH
$4.89B
| $280K | 0.05% |
3,942
-874
| -18% | -$54.9K |
|
767
Beam Therapeutics
BEAM
$2.58B
| $280K | 0.05% |
8,779
+1,517
| +21% | +$49.2K |
|
768
Custom Truck One Source
CTOS
$2.44B
| $280K | 0.05% |
+41,496
| New | +$273K |
|
|
EVA
769
DELISTED
Enviva Inc.
EVA
| $278K | 0.05% |
25,609
+7,726
| +43% | +$112K |
|
770
Realty Income
O
$61.1B
| $278K | 0.05% |
+4,646
| New | +$284K |
|
|
PRSU
771
Pursuit Attractions and Hospitality Inc
PRSU
$1.46B
| $278K | 0.05% |
+10,334
| New | +$230K |
|
772
Amalgamated Financial
AMAL
$1.46B
| $277K | 0.05% |
+17,235
| New | +$277K |
|
773
GigaCloud Technology
GCT
$1.46B
| $277K | 0.05% |
+40,967
| New | +$254K |
|
774
Puma Biotechnology
PBYI
$407M
| $277K | 0.05% |
78,450
-3,169
| -4% | -$9.89K |
|
775
Frontdoor
FTDR
$5.1B
| $276K | 0.05% |
8,662
-3,061
| -26% | -$91.2K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.